Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Vincerx Pharma, Inc. (VINC)

Compare
0.5750
+0.0456
+(8.61%)
At close: April 1 at 4:00:00 PM EDT
0.5800
+0.00
+(0.87%)
After hours: April 1 at 7:59:19 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
31,463
31,463
42,609
68,722
62,656
Operating Income
-31,463
-31,463
-42,609
-68,722
-62,656
Net Non Operating Interest Income Expense
472
472
1,251
664
--
Other Income Expense
917
917
1,201
5,074
23,350
Pretax Income
-30,074
-30,074
-40,157
-62,984
-39,306
Net Income Common Stockholders
-30,074
-30,074
-40,157
-62,984
-39,306
Diluted NI Available to Com Stockholders
-30,074
-30,074
-40,157
-62,984
-39,306
Basic EPS
-15.85
--
-37.72
-62.20
-45.80
Diluted EPS
-15.85
--
-37.72
-62.20
-45.80
Basic Average Shares
1,898
--
1,065
1,051.4500
858.8000
Diluted Average Shares
1,898
--
1,065
1,051.4500
858.8000
Total Operating Income as Reported
-31,463
-31,463
-42,609
-71,191
-62,656
Total Expenses
31,463
31,463
42,609
68,722
62,656
Net Income from Continuing & Discontinued Operation
-30,074
-30,074
-40,157
-62,984
-39,306
Normalized Income
-30,257
-30,257
-40,110
-66,818
-62,664
Interest Income
472
472
1,251
664
--
Net Interest Income
472
472
1,251
664
--
EBIT
-31,463
-31,463
-42,609
-68,722
-62,656
EBITDA
-30,373
-30,373
-41,694
-67,783
-62,316
Reconciled Depreciation
1,090
1,090
915
939
340
Net Income from Continuing Operation Net Minority Interest
-30,074
-30,074
-40,157
-62,984
-39,306
Total Unusual Items Excluding Goodwill
183
183
-47
3,834
23,358
Total Unusual Items
183
183
-47
3,834
23,358
Normalized EBITDA
-30,556
-30,556
-41,647
-71,617
-85,674
12/31/2021 - 5/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PLRZ Polyrizon Ltd.
0.3646
-1.19%
 
AEON AEON Biopharma, Inc.
0.5936
+2.43%
 
REVB Revelation Biosciences, Inc.
2.6000
-1.14%
 
CDT Conduit Pharmaceuticals Inc.
0.7221
-7.54%
 
ELEV Elevation Oncology, Inc.
0.2475
-4.48%
 
ONCO Onconetix, Inc.
0.0757
-2.95%
 
ELAB PMGC Holdings Inc.
4.3300
-6.48%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
1.8900
+5.00%
 
AZTR Azitra, Inc.
0.2900
-4.29%
 
ENTO Entero Therapeutics, Inc.
0.4101
-14.58%